***Background.*** Preventing the spread of carbapenem-resistant Enterobacteriaceae (CRE) is important to public health because of high infection-related morbidity, mortality, and cost. Carbapenemase producing (CP)-CRE are most concerning because of their rapid global dissemination. In 2013, CRE in Oregon were defined as Enterobacteriaceae with non-susceptibility to ≥1 carbapenem, including ertapenem, and resistance to any 3^rd^generation cephalosporin. Review of surveillance data raised concerns of poor definition specificity for CP-CRE creating burden for laboratories and public health investigators.

***Methods.*** We analyzed all CRE isolates reported in Oregon December 2010 -- October 2013. We reviewed surveillance data from other states and published literature, focusing on CRE minimal inhibitory concentration breakpoints.

***Results.*** Of our 125 unique isolates, 75 (60%) were *Enterobacter cloacae*, 13 (10%) *Enterobacter aerogenes*, 11 (9%) *Escherichia coli*, 11 (9%) *Klebsiella pneumoniae*, and 14 (11%) were other species. Non-susceptibility only to ertapenem was demonstrated by 66 (53%), of which 47 (72%) were *E. cloacae.* Of the 34 isolates non-susceptible to multiple carbapenems, 18 (53%) were *E. cloacae,* 5 (15%) *E. aerogenes,* 4 (12%) *E. coli,* and 6 (18%) *K. pneumoniae*. Ninety-nine (81%) isolates were resistant to all 3^rd^ generation cephalosporins tested. Three were CP-CRE; all were *K. pneumoniae* producing *K. pneumoniae* carbapenemases.

Review of literature and other states\' data confirmed carbapenemases were present in *E. cloacae.* Excluding ertapenem from the definition for laboratories using the updated Clinical Laboratory Standard Institute (CLSI) breakpoints did not greatly reduce sensitivity for the most common carbapenemases. Finally, retaining the cephalosporin-resistance requirement enhanced specificity. The new definition decreased the number of cases to investigate by 57%, without missing any CP-CRE.

***Conclusion.*** We modified our case definition to increase CP-CRE specificity, without losing sensitivity, thus decreasing investigation burden. For laboratories using current CLSI breakpoints, the new definition includes all Enterobacteriaceae*,* removes ertapenem, and requires resistance to all 3^rd^ generation cephalosporins tested.
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